{
  "metadata": {
    "timestamp": "2025-12-12T12:10:27.235993",
    "genes": [
      "SERPINE1",
      "EMP1",
      "SPOCD1",
      "ARHGAP29",
      "IL1R1",
      "COL6A2",
      "MYOF",
      "F13A1",
      "CXCL10",
      "CHI3L1",
      "MET",
      "IL6",
      "SAA2",
      "BIRC3",
      "MCTP2",
      "ANGPTL4",
      "ICAM1",
      "CCN1",
      "CAV1",
      "APLN",
      "FOSL1",
      "SNTG2-AS1",
      "TPD52L1",
      "SAA4",
      "KRT75",
      "NFATC2",
      "COL5A1",
      "AC243829.2",
      "CLCF1",
      "ARSJ",
      "PLA2G2A",
      "HMGA2",
      "PTX3",
      "TLR2",
      "LINC00698",
      "ALPK2",
      "TNFAIP3",
      "TNFAIP2",
      "NDRG1",
      "SMOC2",
      "ADGRL2",
      "KANK4",
      "GEM",
      "FAS",
      "CXCL8",
      "CFH",
      "ABCC3",
      "CXCL14",
      "ZFP36",
      "RCAN2",
      "GADD45A",
      "COL1A2",
      "LTF",
      "DHRS3",
      "IDO1",
      "HAP1",
      "AXL",
      "ATP6V0D2",
      "KLF5",
      "ST6GALNAC5",
      "GPD1",
      "PAPPA2",
      "BAG3",
      "MYBPH",
      "MYBPC1",
      "MX2",
      "APBB1IP",
      "ANPEP",
      "ALPL",
      "GPRC5A",
      "SPP1",
      "CXCL2",
      "GPC5",
      "RRAD",
      "LIF",
      "CHRNA9",
      "IL4R",
      "NPNT",
      "SAA1",
      "NPR3",
      "PROM1",
      "SLIT3",
      "ITGBL1",
      "MYO5B",
      "RPS5",
      "RPS27",
      "ETS2",
      "PTGS2",
      "RPS18",
      "BNC2",
      "CPA4",
      "NPAS2",
      "CD274",
      "SLC10A6",
      "LRAT",
      "LINC01993",
      "LINC02832",
      "LINC02821",
      "GBP5",
      "AC021851.2",
      "AKAP12",
      "LINC02154",
      "FN1",
      "MIR222HG",
      "VEGFA",
      "GBP2",
      "ZNF735",
      "TSHZ2",
      "TRPM2",
      "LUCAT1",
      "PI3"
    ],
    "context": "malignant glioblastoma cells",
    "validation_status": "valid",
    "raw_file_reference": "outputs/glioblastoma_langpa_test/0_glioblastoma/20251212_121027/deepsearch.json",
    "source": "scripts/run_deepsearch.py",
    "preset": null,
    "template": null,
    "custom_prompt_used": false,
    "provider_override": null,
    "model_override": null,
    "reasoning_effort_override": null,
    "search_recency_override": null,
    "timeout_seconds": 180,
    "effective_provider": "offline",
    "effective_model": "offline",
    "project": "glioblastoma_langpa_test",
    "query": "0_glioblastoma",
    "source_tag": "deepsearch",
    "resolve_citations": true,
    "citation_flags": {
      "validate": true,
      "scrape": false,
      "pdf": true,
      "topic_validation": false
    }
  },
  "structured_data": {
    "context": {
      "cell_type": "malignant glioblastoma cells",
      "disease": "glioblastoma (GBM)",
      "tissue": "brain"
    },
    "input_genes": [
      "SERPINE1",
      "EMP1",
      "SPOCD1",
      "ARHGAP29",
      "IL1R1",
      "COL6A2",
      "MYOF",
      "F13A1",
      "CXCL10",
      "CHI3L1",
      "MET",
      "IL6",
      "SAA2",
      "BIRC3",
      "MCTP2",
      "ANGPTL4",
      "ICAM1",
      "CCN1",
      "CAV1",
      "APLN",
      "FOSL1",
      "SNTG2-AS1",
      "TPD52L1",
      "SAA4",
      "KRT75",
      "NFATC2",
      "COL5A1",
      "AC243829.2",
      "CLCF1",
      "ARSJ",
      "PLA2G2A",
      "HMGA2",
      "PTX3",
      "TLR2",
      "LINC00698",
      "ALPK2",
      "TNFAIP3",
      "TNFAIP2",
      "NDRG1",
      "SMOC2",
      "ADGRL2",
      "KANK4",
      "GEM",
      "FAS",
      "CXCL8",
      "CFH",
      "ABCC3",
      "CXCL14",
      "ZFP36",
      "RCAN2",
      "GADD45A",
      "COL1A2",
      "LTF",
      "DHRS3",
      "IDO1",
      "HAP1",
      "AXL",
      "ATP6V0D2",
      "KLF5",
      "ST6GALNAC5",
      "GPD1",
      "PAPPA2",
      "BAG3",
      "MYBPH",
      "MYBPC1",
      "MX2",
      "APBB1IP",
      "ANPEP",
      "ALPL",
      "GPRC5A",
      "SPP1",
      "CXCL2",
      "GPC5",
      "RRAD",
      "LIF",
      "CHRNA9",
      "IL4R",
      "NPNT",
      "SAA1",
      "NPR3",
      "PROM1",
      "SLIT3",
      "ITGBL1",
      "MYO5B",
      "RPS5",
      "RPS27",
      "ETS2",
      "PTGS2",
      "RPS18",
      "BNC2",
      "CPA4",
      "NPAS2",
      "CD274",
      "SLC10A6",
      "LRAT",
      "LINC01993",
      "LINC02832",
      "LINC02821",
      "GBP5",
      "AC021851.2",
      "AKAP12",
      "LINC02154",
      "FN1",
      "MIR222HG",
      "VEGFA",
      "GBP2",
      "ZNF735",
      "TSHZ2",
      "TRPM2",
      "LUCAT1",
      "PI3"
    ],
    "programs": [
      {
        "program_name": "IL-1β-CXCL10-CD8 T Cell Recruitment",
        "description": "The inflammasome-CXCL10 axis mediates CD8 T cell recruitment into glioblastoma tumors through IL-1β-dependent signaling. IL-1β activates IL-1R1 on glioblastoma cells to induce CXCL10 production, which serves as a potent chemoattractant for CD8 T cells. The AIM2 inflammasome triggers IL-1β cleavage and release, enabling this critical immune recruitment pathway. This program represents a potential therapeutic target for enhancing immune surveillance in immunologically cold tumors.",
        "atomic_biological_processes": [
          {
            "name": "inflammasome activation and IL-1β cleavage",
            "citations": [
              {
                "source_id": "2",
                "notes": "AIM2 inflammasome activation triggers caspase-1-mediated IL-1β cleavage in lung cancer cells"
              }
            ],
            "genes": [
              "IL1R1"
            ]
          },
          {
            "name": "CXCL10-mediated chemotaxis",
            "citations": [
              {
                "source_id": "2",
                "notes": "IL-1β induces CXCL10 expression by cancer cells, which mediates CD8 T cell recruitment"
              }
            ],
            "genes": [
              "CXCL10"
            ]
          },
          {
            "name": "CD8 T cell infiltration and activation",
            "citations": [
              {
                "source_id": "2",
                "notes": "CXCL10 production enables CD8 T cell accumulation and activation in tumor microenvironment"
              }
            ],
            "genes": [
              "CXCL10",
              "IL1R1"
            ]
          }
        ],
        "atomic_cellular_components": [],
        "predicted_cellular_impact": [
          "Enhanced IL-1β signaling through IL-1R1 amplifies CXCL10 production",
          "Increased CD8 T cell recruitment at tumor site",
          "Potential for enhanced chemo-immunotherapy efficacy when IL-1β pathway is activated"
        ],
        "evidence_summary": "The IL-1β/IL-1R1/CXCL10 axis is well-established in murine and human lung cancer models, with robust evidence that IL-1β triggers CXCL10 production in an autocrine manner, enabling CD8 T cell infiltration. Knockdown of CXCL10 completely abolishes the anti-tumor effects of chemo-immunotherapy combined with IL-1β, indicating this axis is necessary for immune control. The AIM2 inflammasome is widely expressed in cancer cell lines and elevated in cancer tissues compared to normal tissues, positioning it as a key upstream activator.",
        "significance_score": 0.85,
        "citations": [
          {
            "source_id": "2",
            "notes": "IL-1β essential for CXCL10 production and CD8 T cell recruitment; AIM2 inflammasome activation drives IL-1β release"
          }
        ],
        "supporting_genes": [
          "IL1R1",
          "CXCL10"
        ]
      },
      {
        "program_name": "Inflammatory Cytokine Network",
        "description": "A multi-component inflammatory program involving interleukins (IL-6, IL-4R, LIF), acute-phase proteins (SAA1, SAA2, SAA4, PTX3), and associated signaling molecules that establish a pro-inflammatory tumor microenvironment. This program drives both immune cell recruitment and immune tolerance through redundant cytokine signaling. PTX3 participates in innate immunity through complement component interaction, while SAA proteins are markers of acute phase response and disease aggressiveness.",
        "atomic_biological_processes": [
          {
            "name": "IL-6 and IL-4R-mediated immune signaling",
            "citations": [
              {
                "source_id": "4",
                "notes": "IL-6 functions in inflammation and B cell maturation"
              },
              {
                "source_id": "21",
                "notes": "IL-6 encodes a cytokine with roles in inflammation and immune cell differentiation"
              }
            ],
            "genes": [
              "IL6",
              "IL4R"
            ]
          },
          {
            "name": "Acute phase protein production",
            "citations": [
              {
                "source_id": "30",
                "notes": "PTX3 is an acute-phase protein involved in innate immunity and complement interaction"
              },
              {
                "source_id": "46",
                "notes": "PTX3 interacts with C1q, factor H, ficolins, and mannan-binding lectin"
              },
              {
                "source_id": "31",
                "notes": "SAA1 is an acute phase protein contributing to disease phenotypes"
              }
            ],
            "genes": [
              "PTX3",
              "SAA1",
              "SAA2",
              "SAA4"
            ]
          },
          {
            "name": "LIF-mediated leukemia inhibitory factor signaling",
            "citations": [
              {
                "source_id": "25",
                "notes": "LIF is an IL-6 family cytokine with roles in stem cell signaling"
              }
            ],
            "genes": [
              "LIF"
            ]
          }
        ],
        "atomic_cellular_components": [],
        "predicted_cellular_impact": [
          "Establishment of pro-inflammatory tumor microenvironment through cytokine redundancy",
          "Recruitment and polarization of immune effector cells",
          "Creation of immune-tolerant niche through IL-4R and alternative activation pathways",
          "Complement activation and regulation through PTX3"
        ],
        "evidence_summary": "The inflammatory cytokine network is characterized by multiple cytokines (IL-6, IL-4R, LIF, PTX3) operating in concert to establish and maintain a pro-tumor microenvironment. IL-6 is a well-characterized inflammatory cytokine with established roles in B cell maturation and inflammation. SAA proteins are recognized as acute-phase markers enriched in aggressive disease states. PTX3 bridges innate immunity and complement activation. The redundancy of this network likely explains the robust inflammatory phenotype of glioblastomas and suggests that targeting single cytokines may be insufficient for therapeutic benefit.",
        "significance_score": 0.78,
        "citations": [
          {
            "source_id": "4",
            "notes": "IL-6 cytokine functions in inflammation and B cell maturation"
          },
          {
            "source_id": "30",
            "notes": "PTX3 acute-phase protein involved in innate immunity"
          },
          {
            "source_id": "31",
            "notes": "SAA1 as acute-phase protein marker of disease"
          },
          {
            "source_id": "28",
            "notes": "Acute-phase protein signatures enriched in aggressive disease with immune response associations"
          }
        ],
        "supporting_genes": [
          "IL6",
          "IL4R",
          "LIF",
          "SAA1",
          "SAA2",
          "SAA4",
          "PTX3"
        ]
      },
      {
        "program_name": "Extracellular Matrix Remodeling and Invasion",
        "description": "A comprehensive program coordinating matrix protein production (COL1A2, COL5A1, COL6A2, FN1), protease inhibition (SERPINE1), and matrix-associated factors (SMOC2, ANPEP, SPP1, ITGBL1) that collectively remodel the tumor microenvironment to facilitate glioblastoma cell invasion and migration. SERPINE1 (PAI-1) serves as a critical hub integrating protease activity with pro-invasive signaling. Spatial profiling reveals distinct ECM signatures in different tumor regions, suggesting coordinated ECM remodeling by specialized cell populations.",
        "atomic_biological_processes": [
          {
            "name": "SERPINE1-mediated protease inhibition and invasion promotion",
            "citations": [
              {
                "source_id": "3",
                "notes": "Enhanced PAI-1 expression associated with glioblastoma invasion"
              },
              {
                "source_id": "7",
                "notes": "PAI-1 regulates glioblastoma invasion through protease inhibition"
              }
            ],
            "genes": [
              "SERPINE1"
            ]
          },
          {
            "name": "Collagen and fibronectin matrix deposition",
            "citations": [
              {
                "source_id": "56",
                "notes": "Spatial profiling identified nearly 400 ECM genes with unique expression patterns in different GBM cell populations"
              }
            ],
            "genes": [
              "COL1A2",
              "COL5A1",
              "COL6A2",
              "FN1"
            ]
          },
          {
            "name": "Matrix-associated factor production",
            "citations": [
              {
                "source_id": "56",
                "notes": "ECM-producing cell populations including endothelial cells and macrophages show spatially distinct signatures"
              }
            ],
            "genes": [
              "SMOC2",
              "ANPEP",
              "SPP1",
              "ITGBL1"
            ]
          }
        ],
        "atomic_cellular_components": [
          {
            "name": "extracellular matrix structure",
            "citations": [
              {
                "source_id": "56",
                "notes": "ECM components establish spatial architecture in glioblastoma microenvironment"
              }
            ],
            "genes": [
              "COL1A2",
              "COL5A1",
              "COL6A2",
              "FN1",
              "SMOC2"
            ]
          }
        ],
        "predicted_cellular_impact": [
          "Enhanced ECM deposition establishing pro-invasive microenvironment",
          "Protease regulation through SERPINE1 enabling selective proteolysis",
          "Spatial organization of tumor niches through distinct ECM signatures",
          "Facilitation of vessel co-option and brain parenchyma infiltration"
        ],
        "evidence_summary": "The extracellular matrix remodeling program is well-supported by spatial transcriptomic profiling revealing nearly 400 ECM genes with distinct expression signatures in different GBM populations. SERPINE1 (PAI-1) is directly implicated in glioblastoma invasion through multiple studies, with enhanced expression correlating with invasive phenotype. Collagen (COL1A2, COL5A1, COL6A2) and fibronectin (FN1) establish the physical scaffold of the tumor microenvironment. Matrix-associated proteins enable ECM-cell interactions supporting invasion. The spatial heterogeneity of ECM expression suggests that coordinated remodeling by multiple cell types creates permissive niches for tumor cell migration.",
        "significance_score": 0.82,
        "citations": [
          {
            "source_id": "56",
            "notes": "Single-cell spatial profiling identified ~400 ECM genes with distinct expression in GBM populations"
          },
          {
            "source_id": "3",
            "notes": "PAI-1 associated with glioblastoma invasion"
          },
          {
            "source_id": "7",
            "notes": "PAI-1 regulates glioblastoma invasion"
          }
        ],
        "supporting_genes": [
          "SERPINE1",
          "COL1A2",
          "COL5A1",
          "COL6A2",
          "FN1",
          "SMOC2",
          "ANPEP",
          "SPP1",
          "ITGBL1"
        ]
      },
      {
        "program_name": "Pericyte Loss and Mesenchymal Transition",
        "description": "Pericyte depletion (70-80% loss in glioblastoma vasculature) drives a mesenchymal transition characterized by upregulation of stemness and plasticity markers (FOSL1, MET, GEM, GPC5). Pericytes normally orchestrate a tumor-restraining microenvironment through paracrine signaling; their loss promotes a hypoxia-associated mesenchymal-II (MES II) state with enhanced invasion and immune suppression. This program links vascular abnormality to tumor cell phenotypic transformation.",
        "atomic_biological_processes": [
          {
            "name": "pericyte-derived paracrine signaling",
            "citations": [
              {
                "source_id": "15",
                "notes": "Pericytes identified as most active paracrine signaling hub within tumor parenchyma"
              },
              {
                "source_id": "50",
                "notes": "Pericytes orchestrate tumor-restraining microenvironment through strategic positioning near blood vessels"
              }
            ],
            "genes": [
              "GEM"
            ]
          },
          {
            "name": "mesenchymal transition and stemness activation",
            "citations": [
              {
                "source_id": "19",
                "notes": "NF1 regulates mesenchymal GBM plasticity through FOSL1"
              },
              {
                "source_id": "50",
                "notes": "MES II cluster includes FOSL1, MET, CCN4, GRB10, SEMA3C genes associated with stemness and plasticity"
              }
            ],
            "genes": [
              "FOSL1",
              "MET",
              "GPC5"
            ]
          },
          {
            "name": "hypoxia-driven mesenchymal state",
            "citations": [
              {
                "source_id": "50",
                "notes": "MES II cells harbor hypoxia and stress-related genes including Hmox1, Tnc, Gdf15, Hspa9"
              }
            ],
            "genes": [
              "FOSL1",
              "MET",
              "GEM",
              "GPC5"
            ]
          }
        ],
        "atomic_cellular_components": [],
        "predicted_cellular_impact": [
          "Loss of pericyte-mediated tumor suppression upon 70-80% pericyte depletion",
          "Expansion of mesenchymal-II GBM cell state with stemness and invasion features",
          "Increased alternatively activated macrophages and myeloid-derived suppressor cells",
          "Enhanced vessel co-option and tumor cell infiltration along vasculature",
          "Promotion of epithelial-mesenchymal transition programs"
        ],
        "evidence_summary": "The pericyte loss program is extensively characterized through single-cell and spatial transcriptomic analysis of human GBM and mouse models with pericyte depletion (Pdgfb-ret/ret mice). Pericytes represent a dominant paracrine signaling hub despite their low relative abundance. Pericyte depletion correlates with accelerated tumor progression, shorter survival, increased hemorrhage, and necrosis. The mesenchymal-II state expanded in pericyte-depleted tumors expresses markers of stemness (FOSL1), survival signaling (MET), and invasion capability. The mechanistic link between pericyte loss and mesenchymal transition is supported by cell-cell communication analysis revealing increased signaling activity of mesenchymal transformation pathways.",
        "significance_score": 0.88,
        "citations": [
          {
            "source_id": "15",
            "notes": "Pericytes as most active signaling hub; depletion accelerates glioma progression"
          },
          {
            "source_id": "50",
            "notes": "Pericyte depletion drives mesenchymal-II state with increased stemness and invasion markers"
          },
          {
            "source_id": "19",
            "notes": "FOSL1 drives mesenchymal GBM plasticity"
          }
        ],
        "supporting_genes": [
          "FOSL1",
          "MET",
          "GEM",
          "GPC5"
        ],
        "required_genes_not_in_input": {
          "genes": [
            "PDGFB",
            "HIF1A",
            "CCN4",
            "GRB10",
            "SEMA3C",
            "HMOX1",
            "TNC",
            "GDF15"
          ],
          "citations": [
            {
              "source_id": "50",
              "notes": "MES II marker genes include CCN4, GRB10, SEMA3C and hypoxia markers Hmox1, Tnc, Gdf15"
            }
          ]
        }
      },
      {
        "program_name": "Epithelial-Mesenchymal Transition Promotion",
        "description": "A transcription factor and signaling-driven program promoting epithelial-mesenchymal transition (EMT) through EMP1, MET, AXL, FOSL1, and associated signaling molecules. EMP1 directly promotes EMT and extracellular matrix remodeling. MET activation through hepatocyte growth factor signaling drives mesenchymal phenotypic acquisition. CXCR4 expression associates with proneural-to-mesenchymal transition. This program is essential for glioblastoma invasiveness and therapeutic resistance.",
        "atomic_biological_processes": [
          {
            "name": "EMP1-driven EMT and K-RAS signaling",
            "citations": [
              {
                "source_id": "57",
                "notes": "EMP1 promotes epithelial-mesenchymal transition and K-RAS signaling; knockout reduces metastasis"
              }
            ],
            "genes": [
              "EMP1"
            ]
          },
          {
            "name": "MET receptor activation and invasion",
            "citations": [
              {
                "source_id": "15",
                "notes": "Recruited macrophages express HGF reinforcing MET activation on GBM cells"
              },
              {
                "source_id": "50",
                "notes": "MET included in MES II marker genes associated with plasticity and invasion"
              }
            ],
            "genes": [
              "MET"
            ]
          },
          {
            "name": "AXL-mediated survival and invasion signaling",
            "citations": [
              {
                "source_id": "17",
                "notes": "AXL involved in cell growth, migration, aggregation and anti-inflammation"
              }
            ],
            "genes": [
              "AXL"
            ]
          },
          {
            "name": "FOSL1-dependent mesenchymal transcriptional regulation",
            "citations": [
              {
                "source_id": "22",
                "notes": "FOSL1 AP-1 transcription factor regulates mesenchymal GBM plasticity"
              }
            ],
            "genes": [
              "FOSL1"
            ]
          }
        ],
        "atomic_cellular_components": [],
        "predicted_cellular_impact": [
          "Promotion of mesenchymal phenotype through EMP1 and FOSL1",
          "Enhanced cell migration and invasion through MET and AXL activation",
          "Reduced oxidative phosphorylation pathway activity characteristic of progenitor state",
          "Increased K-RAS pathway activation supporting aggressive biology",
          "Facilitation of therapeutic resistance through EMT-associated drug efflux mechanisms"
        ],
        "evidence_summary": "The EMT promotion program is well-supported by studies of EMP1 in pancreatic cancer, where knockout reduced proliferation and metastasis while transcriptomic analysis revealed EMT and ECM remodeling promotion. EMP1 expression inversely correlates with oxidative phosphorylation pathways, indicating metabolic reprogramming toward glycolysis. MET activation through hepatocyte growth factor is confirmed in pericyte-depleted glioblastomas through single-cell analysis. AXL is established as a receptor tyrosine kinase mediating growth and invasion. FOSL1 is directly implicated in mesenchymal GBM plasticity through NF1 regulation. CXCR4 associates with proneural-to-mesenchymal transition in glioblastoma.",
        "significance_score": 0.84,
        "citations": [
          {
            "source_id": "57",
            "notes": "EMP1 promotes EMT and K-RAS signaling; knockout reduces proliferation and metastasis"
          },
          {
            "source_id": "22",
            "notes": "FOSL1 regulates mesenchymal GBM plasticity"
          },
          {
            "source_id": "15",
            "notes": "MET activation through HGF in pericyte-depleted tumors"
          }
        ],
        "supporting_genes": [
          "EMP1",
          "MET",
          "AXL",
          "FOSL1"
        ]
      },
      {
        "program_name": "Metabolic Reprogramming and Hypoxic Adaptation",
        "description": "A metabolic program coordinating shifts from oxidative phosphorylation to aerobic glycolysis, lactate accumulation, and mitochondrial dysfunction in response to hypoxia. Core mechanisms involve HIF-1α-driven upregulation of glycolytic enzymes, mitochondrial fragmentation affecting OXPHOS efficiency, and lactate utilization as both energy source and signaling molecule. Genes including NDRG1, GPD1, HAP1, DHRS3, KLF5, and BAG3 support this metabolic transition.",
        "atomic_biological_processes": [
          {
            "name": "HIF-1α-driven glycolytic upregulation",
            "citations": [
              {
                "source_id": "51",
                "notes": "HIF-1α binds glycolysis-related genes (Glut1, HK2, LDHA, PKM2) enhancing glycolytic activity"
              }
            ],
            "genes": [
              "NDRG1",
              "KLF5"
            ]
          },
          {
            "name": "lactate metabolism and accumulation",
            "citations": [
              {
                "source_id": "6",
                "notes": "SUCLG2 knockdown reduces lactate metabolism; lactate peak significantly higher in tumor core"
              },
              {
                "source_id": "51",
                "notes": "L-lactate promotes GBM malignant progression; treatment upregulates proliferation markers PCNA, cyclin D1, Bcl-2"
              }
            ],
            "genes": [
              "GPD1",
              "DHRS3",
              "NDRG1"
            ]
          },
          {
            "name": "mitochondrial dysfunction and OXPHOS inhibition",
            "citations": [
              {
                "source_id": "6",
                "notes": "SUCLG2 knockdown inhibits mitochondrial oxidative phosphorylation; SUCLG2-LMNA-MFN1 pathway controls fusion/fragmentation"
              },
              {
                "source_id": "51",
                "notes": "Mitochondrial OXPHOS complex proteins (SDHB, ND1, ATP5A) reduced in metabolic stress"
              }
            ],
            "genes": [
              "ATP6V0D2",
              "HAP1"
            ]
          }
        ],
        "atomic_cellular_components": [
          {
            "name": "mitochondrial structure and function",
            "citations": [
              {
                "source_id": "6",
                "notes": "Mitochondrial fusion protein MFN1 degradation drives fragmentation and apoptosis"
              }
            ],
            "genes": [
              "ATP6V0D2",
              "HAP1"
            ]
          }
        ],
        "predicted_cellular_impact": [
          "Enhanced glucose uptake and glycolytic flux in response to hypoxia",
          "Accumulation of lactate to ~40mM in tumor core with multiple signaling roles",
          "Mitochondrial fragmentation reducing OXPHOS efficiency",
          "Sustained cell survival under glucose scarcity through lactate utilization (10-15mM rescues viability)",
          "Metabolic inflexibility enabling selective targeting through metabolic inhibitors"
        ],
        "evidence_summary": "The metabolic reprogramming program is extensively characterized through multiple integrated approaches including MR spectroscopy showing elevated lactate in tumor core, transcriptomic analysis of SUCLG2-mediated metabolic control, and functional studies demonstrating lactate rescue of glioblastoma viability under glucose scarcity. Lactate accumulates to approximately 40mM in tumors, with 10-15mM concentrations sufficient to reverse loss of cell viability under low-glucose conditions. HIF-1α-driven glycolytic upregulation is a well-established hypoxic response. Mitochondrial fragmentation through MFN1 degradation is confirmed as a mechanism of metabolic restriction in SUCLG2-knockdown cells. Lactate treatment directly upregulates proliferation markers and anti-apoptotic proteins.",
        "significance_score": 0.81,
        "citations": [
          {
            "source_id": "6",
            "notes": "SUCLG2 controls mitochondrial metabolism and lactate production in GBM"
          },
          {
            "source_id": "51",
            "notes": "Lactate metabolism drives GBM progression; HIF-1α regulates glycolytic genes"
          }
        ],
        "supporting_genes": [
          "NDRG1",
          "GPD1",
          "HAP1",
          "DHRS3",
          "KLF5",
          "ATP6V0D2"
        ],
        "required_genes_not_in_input": {
          "genes": [
            "HIF1A",
            "GLUT1",
            "HK2",
            "LDHA",
            "PKM2",
            "LMNA",
            "MFN1",
            "DLAT"
          ],
          "citations": [
            {
              "source_id": "51",
              "notes": "HIF-1α regulates Glut1, HK2, LDHA, PKM2; SUCLG2-LMNA-MFN1 axis controls metabolism"
            }
          ]
        }
      },
      {
        "program_name": "Endoplasmic Reticulum Stress and Proteostasis",
        "description": "A bidirectional crosstalk program between endoplasmic reticulum stress and lipid metabolism that maintains proteostasis under metabolic challenge. Through the unfolded protein response (UPR), ER stress reprograms lipid synthesis, oxidation, and storage to sustain energy balance and membrane integrity. Dysregulated lipid accumulation conversely disrupts ER homeostasis, creating feedback loops between metabolic and proteostatic imbalance. Genes including BAG3, TNFAIP3, TNFAIP2, and implicitly ERN1 participate in this adaptive network.",
        "atomic_biological_processes": [
          {
            "name": "unfolded protein response signaling",
            "citations": [
              {
                "source_id": "54",
                "notes": "UPR reprograms lipid synthesis, oxidation, storage through ER stress sensing"
              }
            ],
            "genes": [
              "BAG3",
              "TNFAIP3",
              "TNFAIP2"
            ]
          },
          {
            "name": "lipid metabolism reprogramming",
            "citations": [
              {
                "source_id": "54",
                "notes": "ER stress couples with lipid metabolism in bidirectional regulatory network"
              }
            ],
            "genes": [
              "BAG3",
              "ATP6V0D2",
              "DHRS3"
            ]
          },
          {
            "name": "proteostasis system coordination",
            "citations": [
              {
                "source_id": "54",
                "notes": "Ubiquitin-proteasome system and autophagy cooperate with UPR to fine-tune adaptive balance"
              }
            ],
            "genes": [
              "BAG3",
              "TNFAIP3"
            ]
          }
        ],
        "atomic_cellular_components": [
          {
            "name": "endoplasmic reticulum homeostasis",
            "citations": [
              {
                "source_id": "54",
                "notes": "ER stress central to adaptive response maintaining proteostasis under metabolic challenge"
              }
            ],
            "genes": [
              "BAG3",
              "TNFAIP3"
            ]
          }
        ],
        "predicted_cellular_impact": [
          "Maintenance of proteostasis under metabolic and environmental stress",
          "Coupling of protein quality control with lipid remodeling",
          "Enhanced tumor survival through adaptive stress response",
          "Creation of feedback loops enabling metabolic flexibility",
          "Potential therapeutic vulnerability through combined lipid and UPR targeting"
        ],
        "evidence_summary": "The ER stress-lipid metabolism coupling program is well-characterized through systems approaches examining cancer cell adaptation. ER stress is positioned as a central adaptive response maintaining protein quality control under diverse challenges. The UPR actively reprograms lipid metabolism, coupling protein folding with bioenergetic and biosynthetic adaptation. Dysregulated lipid accumulation disrupts ER homeostasis, creating bidirectional feedback. BAG3 functions as a cochaperone supporting stress-induced autophagy and protein quality control. TNFAIP3 (A20) provides negative feedback on inflammatory signaling while promoting cell survival. The redundancy and feedback nature of this network underlies the robustness of glioblastoma adaptation to metabolic stress.",
        "significance_score": 0.72,
        "citations": [
          {
            "source_id": "54",
            "notes": "Bidirectional crosstalk between ER stress and lipid metabolism maintains tumor adaptation and survival"
          }
        ],
        "supporting_genes": [
          "BAG3",
          "TNFAIP3",
          "TNFAIP2",
          "ATP6V0D2",
          "DHRS3"
        ],
        "required_genes_not_in_input": {
          "genes": [
            "ATF4",
            "ATF6",
            "IRE1A",
            "PERK",
            "CHOP"
          ],
          "citations": [
            {
              "source_id": "54",
              "notes": "UPR involves ATF4, ATF6, IRE1A, PERK and CHOP transcription factors"
            }
          ]
        }
      },
      {
        "program_name": "Immune Checkpoint and Evasion",
        "description": "A multi-layered immune evasion program combining checkpoint ligand expression (CD274/PD-L1), tryptophan depletion (IDO1), complement inhibition (CFH), and anti-apoptotic signaling (FAS, BIRC3) to establish an immunosuppressive microenvironment. CD274 engagement with PD-1 on T cells blocks activation; IDO1 depletes tryptophan enabling regulatory T cell differentiation; CFH inhibits complement cascade. This program directly opposes anti-tumor immunity and represents key therapeutic targets.",
        "atomic_biological_processes": [
          {
            "name": "PD-L1-mediated T cell exhaustion",
            "citations": [
              {
                "source_id": "23",
                "notes": "CD274 (PD-L1) immunosuppressive checkpoint protein integrated with tumor-infiltrating lymphocytes in glioma characterization"
              }
            ],
            "genes": [
              "CD274"
            ]
          },
          {
            "name": "IDO1-mediated tryptophan depletion",
            "citations": [
              {
                "source_id": "62",
                "notes": "IDO1 depletes tryptophan generating kynurenine enabling regulatory T cell differentiation"
              }
            ],
            "genes": [
              "IDO1"
            ]
          },
          {
            "name": "complement regulation through CFH",
            "citations": [
              {
                "source_id": "33",
                "notes": "CFH is complement factor regulating cascade initiation"
              }
            ],
            "genes": [
              "CFH"
            ]
          },
          {
            "name": "death receptor and anti-apoptotic signaling",
            "citations": [
              {
                "source_id": "44",
                "notes": "FAS death receptor involvement in apoptosis"
              }
            ],
            "genes": [
              "FAS",
              "BIRC3"
            ]
          }
        ],
        "atomic_cellular_components": [],
        "predicted_cellular_impact": [
          "Blockade of T cell activation through PD-L1/PD-1 engagement",
          "Tryptophan depletion enabling regulatory T cell differentiation and CD8 T cell exhaustion",
          "Resistance to complement-mediated lysis through CFH-mediated cascade inhibition",
          "Suppression of death receptor-mediated apoptosis",
          "Creation of immunologically cold tumor resistant to checkpoint inhibitors alone"
        ],
        "evidence_summary": "The immune checkpoint evasion program combines multiple redundant mechanisms ensuring robust immune evasion. CD274 (PD-L1) is well-established as an immunosuppressive checkpoint with levels correlating with glioma microenvironment characterization. IDO1 depletes tryptophan and generates kynurenine, enabling regulatory T cell differentiation and CD8 T cell exhaustion through GCN2 kinase activation. CFH is a negative regulator of complement cascade, enabling tumor escape from complement-mediated lysis. FAS death receptor and BIRC3 anti-apoptotic proteins provide redundant survival signals. The redundancy of immune evasion mechanisms (PD-L1, IDO1, complement inhibition) explains the limited efficacy of single-agent checkpoint inhibitors and suggests need for combination approaches.",
        "significance_score": 0.79,
        "citations": [
          {
            "source_id": "23",
            "notes": "CD274 (PD-L1) checkpoint protein in glioma microenvironment"
          },
          {
            "source_id": "62",
            "notes": "IDO1 tryptophan depletion enables regulatory T cell differentiation"
          },
          {
            "source_id": "20",
            "notes": "Trispecific antibody targeting CD3, B7H3, PDL1 to redirect T cells while mitigating immunosuppression"
          }
        ],
        "supporting_genes": [
          "CD274",
          "IDO1",
          "CFH",
          "FAS",
          "BIRC3"
        ]
      },
      {
        "program_name": "Angiogenesis and Vascular Support",
        "description": "A vascular support program coordinating growth factor signaling (VEGFA, ANGPTL4), chemokine-mediated leukocyte recruitment (CXCL8, CXCL2, CXCL14), and adhesion molecule expression (ICAM1) to establish and maintain abnormal tumor vasculature. VEGFA drives endothelial proliferation; ANGPTL4 destabilizes vascular barriers facilitating infiltration; chemokines recruit immune suppressive myeloid cells; ICAM1 mediates leukocyte recruitment and adhesion.",
        "atomic_biological_processes": [
          {
            "name": "VEGFA-driven angiogenesis",
            "citations": [
              {
                "source_id": "8",
                "notes": "VEGFA promotes angiogenic properties of human glioblastoma cells"
              },
              {
                "source_id": "61",
                "notes": "ANGPTL4 and VEGF synergistically destabilize retinal vascular barrier"
              }
            ],
            "genes": [
              "VEGFA"
            ]
          },
          {
            "name": "barrier destabilization through ANGPTL4",
            "citations": [
              {
                "source_id": "61",
                "notes": "ANGPTL4 acts synergistically with VEGF to destabilize vascular barriers"
              }
            ],
            "genes": [
              "ANGPTL4"
            ]
          },
          {
            "name": "chemokine-mediated immune cell recruitment",
            "citations": [
              {
                "source_id": "9",
                "notes": "CXCL8 secreted by macrophages induces PD-L1(+) macrophages in immunosuppressive microenvironment"
              }
            ],
            "genes": [
              "CXCL8",
              "CXCL2",
              "CXCL14"
            ]
          },
          {
            "name": "ICAM1-mediated leukocyte adhesion",
            "citations": [
              {
                "source_id": "18",
                "notes": "High ICAM1 expression associated with glioblastoma"
              }
            ],
            "genes": [
              "ICAM1"
            ]
          }
        ],
        "atomic_cellular_components": [
          {
            "name": "vascular endothelium and blood-brain barrier",
            "citations": [
              {
                "source_id": "50",
                "notes": "Glioblastoma vasculature characterized by microvascular proliferation and functional abnormality"
              }
            ],
            "genes": [
              "VEGFA",
              "ANGPTL4",
              "ICAM1"
            ]
          }
        ],
        "predicted_cellular_impact": [
          "Enhanced endothelial cell proliferation driving microvascular proliferation characteristic of GBM",
          "Vascular barrier destabilization facilitating tumor cell infiltration",
          "Recruitment of immunosuppressive myeloid cells through chemokine signaling",
          "Facilitation of tumor cell migration along blood vessels",
          "Disruption of blood-brain barrier enabling peripheral immune cell entry"
        ],
        "evidence_summary": "The angiogenesis program is well-supported by established roles of VEGFA in glioblastoma angiogenesis and vascular proliferation. ANGPTL4 is documented to synergize with VEGF in barrier destabilization, enabling tumor cell infiltration. CXCL8 is shown to induce immunosuppressive macrophage polarization, linking angiogenic and immune suppressive programs. ICAM1 is highly expressed in glioblastoma and regulates leukocyte recruitment. The convergence of pro-angiogenic signals (VEGFA, ANGPTL4), chemotactic factors (CXCL8, CXCL2), and adhesion molecules (ICAM1) creates an interconnected program supporting both vascular abnormality and immune cell infiltration.",
        "significance_score": 0.75,
        "citations": [
          {
            "source_id": "8",
            "notes": "VEGFA promotes angiogenic properties in glioblastoma"
          },
          {
            "source_id": "61",
            "notes": "ANGPTL4 and VEGF synergistically destabilize vascular barriers"
          },
          {
            "source_id": "9",
            "notes": "CXCL8 induces immunosuppressive macrophage polarization"
          },
          {
            "source_id": "18",
            "notes": "High ICAM1 associated with glioblastoma"
          }
        ],
        "supporting_genes": [
          "VEGFA",
          "ANGPTL4",
          "CXCL8",
          "CXCL2",
          "CXCL14",
          "ICAM1"
        ]
      },
      {
        "program_name": "Cell Survival and Anti-apoptotic Signaling",
        "description": "An integrated survival program employing multiple anti-apoptotic mechanisms including inhibitors of apoptosis (BIRC3), negative feedback regulators of inflammatory signaling (TNFAIP3, TNFAIP2), death receptor signaling (FAS), and protein quality control (BAG3). BIRC3 directly inhibits caspases; TNFAIP3 (A20) provides negative feedback on NF-κB; TNFAIP2 suppresses TNF signaling; BAG3 supports stress-induced autophagy and survival. This program enables glioblastoma cell survival under apoptotic pressure.",
        "atomic_biological_processes": [
          {
            "name": "caspase inhibition through BIRC3",
            "citations": [
              {
                "source_id": "11",
                "notes": "BIRC3 encodes inhibitor of apoptosis suppressing caspase activation"
              }
            ],
            "genes": [
              "BIRC3"
            ]
          },
          {
            "name": "NF-κB negative feedback through TNFAIP3",
            "citations": [
              {
                "source_id": "32",
                "notes": "TNFAIP3 (A20) induced by TNF-alpha and NF-κB providing negative feedback limiting inflammatory signaling"
              }
            ],
            "genes": [
              "TNFAIP3"
            ]
          },
          {
            "name": "TNF-alpha signaling suppression",
            "citations": [
              {
                "source_id": "52",
                "notes": "TNFAIP2 suppresses TNF signaling pathways"
              }
            ],
            "genes": [
              "TNFAIP2"
            ]
          },
          {
            "name": "stress-induced autophagy and protein quality control",
            "citations": [
              {
                "source_id": "54",
                "notes": "BAG3 functions as cochaperone supporting stress-induced autophagy enabling survival"
              }
            ],
            "genes": [
              "BAG3"
            ]
          }
        ],
        "atomic_cellular_components": [],
        "predicted_cellular_impact": [
          "Direct caspase inhibition preventing apoptotic cascade initiation",
          "Negative feedback limiting inflammatory-induced apoptosis",
          "Enhanced protein quality control and selective autophagy",
          "Reduced death receptor-mediated apoptosis",
          "Enhanced survival under metabolic and proteostatic stress"
        ],
        "evidence_summary": "The anti-apoptotic program employs redundant survival mechanisms ensuring robust protection from apoptotic stimuli. BIRC3 is a canonical inhibitor of apoptosis directly suppressing caspase activation. TNFAIP3 (A20) provides well-characterized negative feedback on NF-κB signaling while simultaneously promoting cell survival, suggesting it functions as a molecular switch preventing excessive inflammation-induced apoptosis. TNFAIP2 similarly suppresses TNF signaling. BAG3 is a cochaperone supporting stress-induced autophagy as an adaptive response enabling cell survival. The convergence of caspase inhibition, inflammatory signal suppression, and protein quality control creates robust protection from apoptosis.",
        "significance_score": 0.7,
        "citations": [
          {
            "source_id": "11",
            "notes": "BIRC3 inhibitor of apoptosis suppressing caspase activation"
          },
          {
            "source_id": "32",
            "notes": "TNFAIP3 negative feedback on NF-κB and inflammatory signaling"
          },
          {
            "source_id": "54",
            "notes": "BAG3 supports stress-induced autophagy and tumor survival"
          }
        ],
        "supporting_genes": [
          "BIRC3",
          "TNFAIP3",
          "TNFAIP2",
          "FAS",
          "BAG3"
        ]
      }
    ],
    "method": {
      "clustering_basis": [
        "pathway integration from search results and NCBI gene records",
        "co-expression in glioblastoma tumor microenvironment based on single-cell transcriptomics",
        "functional validation in multiple experimental systems",
        "mechanistic studies linking genes to phenotypic outcomes"
      ],
      "notes": "Programs identified through systematic integration of literature evidence establishing functional relationships between input genes and biological processes. Strong support for IL-1β-CXCL10 axis, pericyte-mesenchymal transition coupling, SERPINE1-invasion linkage, and metabolic-immunological integration. Prioritized programs with multiple input genes functioning in same pathway and strong experimental support. Programs ranked by significance based on supporting genes, citation density, and contextual relevance to malignant glioblastoma."
    },
    "version": "1.0"
  }
}